CEACAM8-related method for treating autoimmune diseases
US8309091B2 · kind B2 · utility
0Cited by
4References
2Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 31, 2006 |
| Grant date | Nov 13, 2012 |
| Priority date | — |
| Expiry date | Jun 3, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/73
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the use of substances which are specific to CEACAM8 for the manufacture of a medicament for the prophylactic or therapeutic treatment of human autoimmune diseases and/or gout. Another object of the invention concerns the use of CEACAM8-specific substances for apoptosis induction in-vitro. The invention also relates to a method for screening substances which induce apoptosis and a method for inducing apoptosis in human granulocytes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.